In this community, professionals share information regarding the clinical, programmatic and community-oriented aspects of early diagnosis, treatment and prevention of multi-drug-resistant tuberculosis (MDR-TB). Members also use this forum to promote universal access to quality care for MDR-TB.

Community moderators

Masoud Dara, MD
WHO Europe - EURO
Christopher Gilpin, PhD, MPH
World Health Organization - WHO
Dylan Tierney
Brigham and Women's Hospital, Division of Global Health Equity

Recent community activity

Updated: 26 May, 2017
Replies: 6

faropenem and xdrtb

by jeetesh singh

would this drug be a potential in far flung area without monitoring needs as in delamanid ? any experiences please share jeet read more

Updated: 26 May, 2017
Replies: 0

Final Reminder: "Rand, Real, Renminbi, Rubles, and Rupees for Research in TB" --30 May

by Erica Lessem

Hi all, A final reminder to register to TAG/ACTION webinars on May 30, June 6 to read more

Updated: 25 May, 2017
Replies: 0
Updated: 23 May, 2017
Replies: 10

New community members

User Photo

Luis Fajardo

Affiliated Organizations

Hospital Santa Rosa

Work Locations

Peru

User Photo

SABASTINE ESOMONU

Affiliated Organizations

HEALTH

Work Locations

Nigeria

User Photo

Diana Gomez

Affiliated Organizations

Doctors Without Borders/Médecins Sans Frontières, Holland - (MSF)

Work Locations

Netherlands